Basking Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Basking Biosciences's estimated annual revenue is currently $1.9M per year.
- Basking Biosciences's estimated revenue per employee is $155,000
Employee Data
- Basking Biosciences has 12 Employees.
- Basking Biosciences grew their employee count by 9% last year.
Basking Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Founder, Chief Medical Officer | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Head Development Operations | Reveal Email/Phone |
Basking Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $2M | 13 | 0% | N/A | N/A |
#3 | $0.8M | 5 | 0% | N/A | N/A |
#4 | $6.2M | 40 | 14% | N/A | N/A |
#5 | $68.7M | 443 | 6% | N/A | N/A |
#6 | $97.2M | 448 | 17% | $330M | N/A |
#7 | $1.9M | 12 | 9% | N/A | N/A |
#8 | $2.5M | 16 | 220% | N/A | N/A |
#9 | $7M | 45 | -6% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Basking Biosciences?
Basking Biosciences is developing a novel first-line therapy (BB-031) targeting von Willebrand Factor (vWF), along with a direct acting reversal agent (BB-025) to immediately neutralize the pharmacological effect of BB-031 in the event of bleeding. BB-031 is an RNA aptamer optimized for rapid onset of action and short duration of effect. BB-031 is being evaluated in patients with acute ischemic stroke (AIS) in the RAISE trial, a two-part Phase 2 study assessing the safety and preliminary efficacy of the investigational drug candidate. The technology is based on two decades of translational research on RNA aptamers as therapeutic agents for cardiovascular diseases.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Columbus
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 12 | N/A | N/A |
#2 | $0.7M | 12 | 100% | $11.6M |
#3 | $1M | 12 | N/A | N/A |
#4 | $0.4M | 12 | -33% | $4.9M |
#5 | $1M | 12 | N/A | N/A |